Drugs / Trypsin-Chymotrypsin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06562816 | Aug → Nov 2024 overdue | — | Dow University of Health Sciences | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trypsin-Chymotrypsin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06562816 ↗ |
| Route | Oral | “containing oral formulations of Trypsin:Chymotryspin” NCT06562816 ↗ |